"We are proud to contribute to research in head and neck and other forms of cancer to learn more about causes and treatments.

Poor oral hygiene can lead to cavities, which increase the chance of developing certain cancers. Read about the connection, ...

A team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the ...

Mean dose to the tongue mucosa did not improve predictions of taste impairment during and after radiation therapy compared ...

Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...

HPV causes irritating warts, or lesions, on the back, front, or side of the tongue. Males have a higher risk of developing ...

the company's drug candidate for the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). The FDA's Fast Track designation program is ...

Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new ...

About Head and Neck Squamous Cell Carcinoma (HNSCC) Head and Neck Cancer (HNC) is the sixth most common cancer in the world, with 1,464,550 new cases and 487,993 deaths from HNC globally1.